What are the phases of the hair growth cycle (anagen, catagen, telogen, and kenogen) and their typical durations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hair Growth Cycle Phases

The hair growth cycle consists of four distinct phases: anagen (growth phase lasting 2-7 years), catagen (regression phase lasting 2-3 weeks), telogen (resting phase lasting 2-4 months), and kenogen (empty follicle phase lasting 2-7 months after hair shedding). 1, 2

Anagen (Growth Phase)

The anagen phase represents active hair growth where the follicle is producing the hair shaft. This is the longest phase of the cycle, typically lasting 2-7 years for scalp hair 3, 4. During this phase, hair follicles are firmly anchored and demonstrate strong cohesion forces correlated with hair thickness 5. The duration of anagen determines the maximum length hair can achieve, which explains why scalp hair grows much longer than body hair.

Catagen (Regression Phase)

Catagen is an apoptosis-driven regression phase lasting approximately 2-3 weeks 3, 4. During this brief transitional period, the hair follicle undergoes controlled involution, the hair shaft stops growing, and the follicle begins to detach from its blood supply. This phase marks the end of active hair production and prepares the follicle for the resting phase.

Telogen (Resting Phase)

The telogen phase represents a period of relative quiescence lasting 2-4 months 3, 4. During telogen, the hair remains in the follicle as a "club hair" but is no longer growing. The follicle is preparing for either the next anagen phase or hair shedding. Telogen hair are firmly anchored to the hair follicle and retain cellular elements of the outer root sheath 5.

Kenogen (Empty Follicle Phase)

Kenogen is a physiological interval where the hair follicle remains empty after the telogen hair has been shed (teloptosis) and before a new anagen hair emerges 2. This phase was more recently characterized and represents an alternative route in the hair cycle.

Kenogen Duration and Clinical Significance:

  • Normal individuals: Affects approximately 8% of follicles, lasting about 2 months in prepubertal children 2
  • Androgenetic alopecia (AGA) patients: Can affect up to 80% of hair cycles in balding males, lasting 4-7 months 2
  • Female AGA: Involves 16-22% of follicles, lasting 3-12 months 2, 6

The increased frequency and duration of kenogen in androgenetic alopecia may account for progressive baldness, as more follicles spend extended periods empty rather than producing hair 2, 6. In women with progressing AGA, kenogen phases increase in parallel with vellus hair transformation and decreased normal hair cycles 6.

Clinical Pitfall:

The kenogen phase is often overlooked in clinical practice but is crucial for understanding pattern hair loss. Minoxidil's mechanism of action specifically targets prolongation of anagen and promotes telogen-to-anagen switching, which effectively shortens or bypasses the kenogen phase 1. This explains why minoxidil remains effective across multiple hair loss conditions where follicles are spending excessive time in kenogen rather than producing terminal hairs.

References

Research

Kenogen. A new phase of the hair cycle?

Dermatology (Basel, Switzerland), 2002

Research

Morphogenesis, Growth Cycle and Molecular Regulation of Hair Follicles.

Frontiers in cell and developmental biology, 2022

Research

Biology of the hair follicle: the basics.

Seminars in cutaneous medicine and surgery, 2006

Research

Exogen hair characterization in human scalp.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2007

Research

Kenogen in female androgenetic alopecia. A longitudinal study.

Dermatology (Basel, Switzerland), 2005

Related Questions

Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 56-year-old male with persistent testicular pain and a normal scrotal ultrasound, would a spermatic cord block be beneficial, and what outcomes and follow‑up treatment should be expected if the block improves his pain?
In a patient with a diagnosed thymoma and myasthenia gravis, should we still order acetylcholine‑receptor antibody testing or proceed directly to thymectomy?
What is the recommended evaluation and management of the extracranial carotid arteries in a patient being assessed for intracranial atherosclerosis, particularly after a transient ischemic attack or minor stroke?
What is the appropriate treatment and follow‑up for a 71‑year‑old patient with mildly active moderate chronic Helicobacter pylori‑associated chronic atrophic gastritis of the fundic mucosa?
Is it safe to take GABA (gamma‑aminobutyric acid), L‑theanine, and magnesium glycinate together?
What is the appropriate management for food poisoning in an adult?
What is the recommended evaluation and management for a 52-year-old patient with hemoglobin 10.4 g/dL and no overt bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.